查詢結果分析
相關文獻
- 頰膜鱗狀上皮細胞癌病患術前鱗狀上皮細胞癌抗原--新預後指標?
- Prognostic Significance of Lymph Node Metastasis in Resected Colorectal Cancer
- Nodal Yield and the Pattern of Cervical Lymph Node Metastasis in Buccal Mucosa Squamous Cell Carcinoma--A Single Institution Retrospective Study
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Postoperative Radiotherapy of Adult Supratentorial High-grade Astrocytoma
- 成人低惡性度顱內星狀細胞瘤之術後放射治療
- Detection of Serum Anti-p53 Antibody in Patients with Renal Cell Carcinoma
- 乳癌預後因子探討--論流式細胞分析儀在乳癌之應用
- Prognostic Factors and Results of Radiotherapy for Brain Stem Gliomas
- Prognostic Value of DNA Ploidy Patterns of Colorectal Adenocarcinoma
頁籤選單縮合
題 名 | 頰膜鱗狀上皮細胞癌病患術前鱗狀上皮細胞癌抗原--新預後指標?=Preoperative Squamous Cell Carcinoma Antigen in Buccal Squamous Cell Carcinoma--A New Prognostic Factor? |
---|---|
作 者 | 吳若萱; 張凱成; 廖俊達; 陳一豪; 康仲然; 黃祥富; | 書刊名 | 臺灣耳鼻喉頭頸外科雜誌 |
卷 期 | 46:6 2011.11-12[民100.11-12] |
頁 次 | 頁310-317 |
分類號 | 416.954 |
關鍵詞 | 頰膜鱗狀上皮細胞癌; 鱗狀上皮細胞癌抗原; 預後因子; 淋巴結轉移; 淋巴結莢膜外侵犯; Buccal squamous cell carcinoma; Squamous cell carcinoma antigen; SCC-Ag; Prognostic factor; Lymph node metastasis; Lymph node extracapsular spread; |
語 文 | 中文(Chinese) |
英文摘要 | OBJECTIVE/HYPOTHESIS: A relationship between elevated serum sqaumous cell carcinoma antigen (SCC-Ag) levels and shorter survival in cancer patients was reported in the literature. Few studies, however, investigated the role of serum SCC-Ag levels in oral squamous cell carcinoma. This study was conducted to analyze the relationship between preoperative SCC-Ag levels, clinicopathologic factors, and prognosis in buccal squamous cell carcinoma (BSCC) patients.STUDY DESIGN: Retrospective case-control study.METHODS: Sixty-seven BSCC and 30 oral leukoplakia patients from Chang Gung Memorial Hospital were retrospectively recruited between November 2006 and March 2011. Serum SCC-Ag levels were measured preoperatively.RESULTS: The mean SCC-Ag level in BSCC patients (mean: 2.34 ng/ml) was significantly higher than the leukoplakia patients (mean: 0.79 ng/ml) (p = 0.001). An SCC-Ag level of ≥ 2.0 ng/ml was significantly associated with the pathologic tumor status (p < 0.001), pathologic nodal status (p = 0.036), and tumor depth (> 10 mm vs ≤ 10 mm, p < 0.001). It was not significantly associated with histological differentiation (p = 0.172). A univariate analysis revealed that positivity for SCC-Ag was associated with disease-free survival (p = 0.012) and overall survival (p = 0.001).CONCLUSIONS: This study demonstrated that preoperative SCC-Ag is a good marker of pathological lymph node metastasis, and an advanced tumor stage in BSCC. The preoperative SCC-Ag level is a potential prognostic indicator, but studies with a longer follow-up period are needed to confirm these results. |
本系統中英文摘要資訊取自各篇刊載內容。